ELITE PHARMACEUTICALS INC /DE/ (ELTP) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 423 transactions totaling $15.2M, demonstrating a bearish sentiment with -$14.4M in net insider flow. The most recent transaction on Oct 2, 2025 involved a sale of 800,000 shares valued at $496.0K.
No significant insider buying has been recorded for ELTP in the recent period.
No significant insider selling has been recorded for ELTP in the recent period.
Based on recent SEC filings, insider sentiment for ELTP is bearish with an Insider Alignment Score of 2/100 and a net flow of -$14.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ELITE PHARMACEUTICALS INC /DE/ (ELTP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading ELTP stock, having executed 423 transactions in the past 90 days. The most active insider is Pharma Llc Epic (Executive), who has made 50 transactions totaling $8.0M.
Get notified when executives and directors at ELTP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Plassche Douglas | Executive | Sale | 800,000 | $0.62 | $496.0K | |
| Aug 25, 2025 | Inc /nv/ Elite Pharmaceuticals | Executive | Option Exercise | 2,500,000 | $0.03 | $75.0K | |
| Aug 22, 2025 | Inc /nv/ Elite Pharmaceuticals | Executive | Sale | 500,000 | $0.52 | $260.0K | |
| Jul 10, 2025 | Kirkov Kirko | Executive | Purchase | 16,366 | $0.59 | $9.7K | |
| Jul 8, 2025 | Plassche Douglas | Executive | Sale | 200,000 | $0.58 | $116.0K | |
| Jul 3, 2025 | Plassche Douglas | Executive | Option Exercise | 2,500,000 | $0.03 | $75.0K | |
| Mar 29, 2024 | A. Hakim Nasrat | Executive | Award | 49,534,368 | $N/A | $0 | |
| Dec 29, 2023 | A. Hakim Nasrat | Executive | Award | 2,223,147 | $0.07 | $155.6K | |
| Nov 22, 2023 | H. Dash Barry | Executive | Award | 547,657 | $0.04 | $21.9K | |
| Nov 22, 2023 | S. Caskey Davis | Executive | Award | 547,657 | $0.04 | $21.9K | |
| Nov 22, 2023 | A. Whitnell Jeffrey | Executive | Award | 547,657 | $0.04 | $21.9K | |
| Aug 28, 2022 | H. Dash Barry | Executive | Award | 459,536 | $0.04 | $18.4K | |
| Aug 28, 2022 | S. Caskey Davis | Executive | Award | 459,536 | $0.04 | $18.4K | |
| Aug 28, 2022 | A. Whitnell Jeffrey | Executive | Award | 459,536 | $0.04 | $18.4K | |
| Jun 30, 2021 | H. Dash Barry | Executive | Award | 295,570 | $0.07 | $20.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 44 | $15.5M | 37.5% |
Sale(S) | 215 | $14.8M | 35.9% |
Conversion(C) | 47 | $4.4M | 10.8% |
Award(A) | 69 | $3.8M | 9.2% |
Exercise(M) | 9 | $2.0M | 4.8% |
Disposition(D) | 26 | $415.6K | 1.0% |
Purchase(P) | 11 | $360.5K | 0.9% |
Gift(G) | 2 | $2.3K | 0.0% |
Insider selling pressure at ELITE PHARMACEUTICALS INC /DE/ has increased, with 21 insiders executing 423 transactions across all time. Total sales of $14.8M significantly outpace purchases of $360.5K, resulting in a net outflow of $14.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.